In the present specification, the solid dispersion (R) -N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl) methyl) -2-methyl-1- (1- Pharmaceutically acceptable compositions comprising (1- (2,2,2-trifluoroethyl) piperidin-4-yl) ethyl) -1H-indole-3-carboxamide, and the dispersion, and various conditions Methods of using the dispersions and compositions in the treatment of [Selection diagram] Fig. 1
展开▼